Patent Expiry
HROW: TOBRADEX ST: recorded patent 7795316 expiry
August 3, 2028 · DEXAMETHASONE; TOBRAMYCIN. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- August 3, 2028
- Company
- HARROW, INC. (HROW)
- Drug
- DEXAMETHASONE; TOBRAMYCIN
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
TOBRADEX ST: recorded patent 7795316 expiry
Orange Book application NDA050818, product 001, listed patent 7795316 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- HARROW, INC. (HROW)
- Drug
- DEXAMETHASONE; TOBRAMYCIN